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who	are	born	at	term	with	a	moderate	or	se-
vere	 encephalopathy	 due	 to	 perinatal	 as-
phyxia	 (hypoxic-ischemic	 encephalopathy,	
HIE)	has	remained	relatively	stable	at	1	per	
1000	births4).	Accordingly,	approximately	80	
infants	per	year	are	born	in	Switzerland	with	
moderate	to	severe	encephalopathy	(Sarnat	
grade	2–3)5)	due	to	perinatal	asphyxia	during	
the	first	hours	of	life.	
In	both	populations,	about	15	%	of	the	children	
die	at	or	soon	after	birth6),	7),	a	rate	compa-
rable	to	or	lower	than	that	of	at-risk	popula-
tions	in	other	nations	with	similar	health	care	
standards8).	Of	the	surviving	infants,	approxi-
mately	 10–15	%	 develop	 a	 severe	 disability	
such	as	cerebral	palsy,	mental	retardation,	or	
severe	sensory	impairment9),	10).		
The	prevalence	of	major	developmental	disa-
bilities	increases	with	more	severe	degree	of	
HIE	or	lower	gestational	age	at	birth.	Impor-
tantly,	moderate	to	mild	neurodevelopmental	
disorders	 can	 also	 occur	 in	 the	 absence	 of	
major	 disabilities	 in	 all	 developmental	 do-
mains,	 including	 learning	 disabilities,	 lan-
guage	delay,	motor	coordination	disorder,	and	
problems	of	behavior	and	social	interaction.	
Some	problems,	such	as	dyscalculia	or	exe-
cutive	function	impairment,	only	become	ap-
parent	 during	 later	 school	 age,	 when	more	
complex	academic	and	cognitive	skills	deve-
lop11),	12),	13).	Overall,	these	problems	occur	in	
approximately	50	%	of	children	with	HIE	Sar-
nat	grade	2–3	or	in	30–50	%	of	children	born	
below	32	weeks	of	gestation15).	
Interestingly,	at	least	in	children	born	preterm,	
health-related	quality	of	life	is	comparable	to	
that	of	their	peers16),	17).	Regarding	long-term	
outcomes,	 the	 prevalence	 of	 neuro	deve-
lopmental	deficits	varies	greatly	depending	on	
country	 and	 the	 sociodemographic	 back-
ground	 of	 the	 study	 populations18),	 19).	 Many	
Introduction
Target population
High-risk	 newborns	 in	 the	 context	 of	 these	
guidelines	are	children	who	were	born	 very	
preterm	(before	32	weeks	gestational	age)	or	
children	who	developed	a	hypoxic	ischaemic	
encephalopathy	(Sarnat	grade	2–3)	during	the	
first	hours	of	life.
Background
In	 recent	 decades,	 technical	 advances	 and	
improved	medical	treatment	have	resulted	in	
better	perinatal	care,	leading	to	significantly	
higher	survival	rates	in	high-risk	newborns.	
Simultaneously,	changing	demographics	such	
as	 older	 maternal	 age	 and	 higher	 rates	 of	
medically	assisted	reproductions	have	led	to	
a	 higher	 rate	 of	 infants	 born	 preterm1).	 In	
Switzerland,	the	rate	of	children	born	with	a	
birth	weight	below	1500g	has	doubled	over	
the	last	three	decades2).	Approximately	800	
preterm	infants	(with	a	gestational	age	below	
32	 weeks)	 are	 born	 in	 Switzerland	 every	
year3).	While	the	rate	of	children	born	preterm	
has	 steadily	 increased,	 the	 rate	 of	 children	
preterm	survivors,	however,	are	in	mainstream	
school	and	are	coping	well	as	they	enter	adult	
life,	although	some	will	continue	to	need	addi-
tional	 health,	 educational,	 and	 social	 ser-
vices20).	 Currently,	 no	 study	 has	 examined	
long-term	 or	 adult	 outcome	 after	 perinatal	
asphyxia.	The	degree	to	which	perceived	im-
provements	between	school	age	and	adult	age	
are	a	result	of	early	intervention	strategies21),	
an	optimal	schooling	system,	or	delayed	matu-
rational	processes	remains	unclear.	
The	Swiss	network	contributes	to	answering	
this	question.	Importantly,	early	detection	of	
a	developmental	problem	is	critical	for	care-
takers,	 parents,	 and	 the	 growing	 child.	 We	
conclude	that	high-risk	newborn	children	 in	
Switzerland	require	repeat,	standardized	and	
detailed	follow-up	examination	at	specialized	
centers,	both	to	assist	 in	their	development	
and	to	answer	important	research	questions.
SwissNeoNet
In	2002,	all	nine	Swiss	perinatal	centers	that	
combine	neonatal	with	developmental-	and/or	
neuropediatric	units	(Geneva,	Lausanne,	Berne,	
Basel,	 Aarau,	 Lucerne,	 Chur,	 Zurich	 and	 St.	
Gallen)	funded	the	Swiss	Neonatal	Network	&	
Follow-up	Group	(SwissNeoNet)	to	coordinate	
reporting	of	mortality,	morbidity,	and	neurode-
velopmental	 outcome	 of	 high-risk	 newborns.	
The	aim	was	to	provide	continuous	 follow-up	
assessments	 of	 high-risk	 newborns	 across	
Switzerland	so	as	 to	 improve	 the	quality	and	
efficiency	of	medical	care	through	a	nationwide	
follow-up	network.	These	assessments	comple-
ment	the	regular	follow-up	assessments	perfor-
med	by	primary	care	providers.	To	ensure	high	
follow-up	 rates,	 additional	 regional	 follow-up	
centers	 (Bellinzona,	 Lugano,	 Münsterlingen,	
Winterthur,	 Fribourg,	 Bienne,	 Neuchatel	 and	
Sion)	were	integrated	into	the	network.
A	 state-of-the-art	 population-based	 online	
registry	for	high-risk	newborns	in	Switzerland	
supports	 the	 network’s	 administration	 and	
provides	a	foundation	for	its	dual	purpose	in	
research	 and	 quality	 control.	 The	most	 im-
portant	diagnoses	and	treatments	are	pros-
pectively	collected	during	the	first	perinatal	
hospitalization,	 and	 standardized	 follow-up	
assessments	are	undertaken	at	two	and	five	
to	six	years	of	age.
Today,	this	registry	holds	continuous	standar-
dized	population-based	data	for	very	preterm	
born	infants	since	2000	and	for	term	infants	
with	HIE	since	201022).	
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Purpose of the follow-up 
examinations of high-risk 
newborns in Switzerland 
The	purpose	of	follow-up	assessments	within	
the	SwissNeoNet	is	to	provide	early	detection	
of	neurodevelopmental	impairments	in	high-
risk	children	using	standardized	assessment	
tools.	 This	 enables	 early	 treatment	 of	 de-
velopmental	 impairments	 and	 facilitates	
parental	 counseling18),	 23),	 24).	 By	 registering	
neuro	developmental	 outcome	 within	 the	
SwissNeoNet,	epidemiological	data	is	gathe-
red	which	 allow	 for	 nationwide,	 population-
based	information	on	outcome	in	both	at-risk	
populations.	
The	present	paper	summarizes	the	standards	
for	follow-up	assessments	elaborated	in	Swit-
zerland	since	2006	by	experienced	follow-up	
specialists	 and	 child	 neurologists.	 These	
standards	were	drawn	from	biannual	structu-
red	 and	 minuted	 network	 meetings	 of	 the	
SwissNeoNet.	They	document	a	consensus	in	
Switzerland	on	how	to	optimally	perform	fol-
low-up	assessments	in	high-risk	newborn	in-
fants.	 They,	 however,	 also	 respect	 regional	
differences	 and	describe	 purpose,	 location,	
content,	follow-up	ages,	and	recruiting	stra-
tegies.
The	Swiss	level	III	neonatology	units	initiated	
a	quality	network	that	covers	more	than	95	%	
of	 Swiss	 newborn	 infants	 born	 below	 32	
weeks	 GA	 and/or	 <	1500	 g	 on	 a	 voluntary	
basis	and	without	government	funding.	Since	
2010,	term	infants	with	HIE	are	also	included	
in	the	register.
This	 network	 monitors	 the	 most	 important	
outcome	variables,	relates	them	to	neonatal	
care,	and	compares	them	between	units,	acti-
vities	which	enable	the	detection	of	potential	
areas	 of	 improvement8).	 Further,	 the	 Swiss	
population	outcomes	are	regularly	compared	
with	published	reports	 from	other	networks	
such	as	the	Vermont	Oxford	Network25)	and	
the	EuroNeoNet26);	this	reveals	that	Switzer-
land	 has	 a	 high	 international	 standard	 in	
neonatal	care.
So	far,	these	international	comparisons	have	
been	restricted	to	outcome	data	at	discharge.	
The	success	of	continuous	progress	in	perina-
tal	medicine	is	often	monitored	by	means	of	
short-term	 outcomes.	 They	 may,	 however,	
result	 in	 long-term	disabilities.	One	notable	
example	of	the	contrast	between	short-	and	
long-term	benefits	arose	from	postnatal	dexa-
methasone	treatment,	facilitating	extubation	
in	very	preterm	infants;	however,	the	use	of	
dexamethasone	was	later	associated	with	an	
increased	risk	of	cerebral	palsy24).	Thus,	the	
epidemiological	monitoring	of	long-term	out-
come	measures	is	essential.
The	 data	 monitoring	 and	 center-to-center	
comparisons	depend	on	the	completeness	of	
data	at	a	population	level	and	on	their	compa-
rability	between	units,	 i.e.	 that	all	units	use	
comparable	test	batteries	at	similar	time	in-
tervals.	In	addition,	the	definitions	of	morbi-
dities	and	impairments	(such	as	moderate	to	
severe	auditory	or	visual	impairment)	need	to	
match	 published	 international	 standards	 to	
allow	comparison	of	Swiss	data	to	internatio-
nal	data.	Finally,	these	definitions	need	to	in-
corporate	regional	language	differences	and	
local	follow-up	standards.
To	improve	neonatal	care	and	outcome	of	fu-
ture	high-risk	newborns,	data	from	follow-up	
assessments	are	continuously	and	prospecti-
vely	 collected	 in	 the	 registry	 and	 linked	 to	
neonatal	data,	which	is	collected	from	birth	
until	discharge.	In	this	way,	the	register	pro-
vides	 an	 invaluable	 tool	 for	 pinpointing	 risk	
factors	 for	 developmental	 impairment.	 Fur-
thermore,	 the	administrative	support	of	 the	
registry	 can	 aid	 follow-up	 recruitment	 and	
organization,	which	 increases	 the	 follow-up	
rate,	to	the	benefit	of	each	participating	cen-
ter	and	ultimately	of	the	children.
Several	 research	 studies	 from	 the	 registry	
have	 contributed	 to	 a	 better	 understanding	
of	 risk	 factors	 for	 adverse	 outcome.	 For	
example,	Schlapbach	et	al.	demonstrated	that	
neonatal	 sepsis	 is	 significantly	 associated	
with	impaired	neurodevelopmental	outcome	
at	two	years	of	age	 in	extremely	preterm27).	
Another	important	finding	of	the	collaborative	
effort	between	neonatologists	and	develop-
mental	 pediatricians	 is	 that	 neurodevelop-
Location Address Telephone
Aarau Neuropädiatrie,	Klinik	für	Kinder	und	Jugendliche,	
Kantonsspital	Aarau	(KSA)
062	838	49	17
Basel Abteilung	für	Neuropädiatrie,	
Universitätskinderspital	Basel	(UKBB)
061	704	19	06
Bern Abteilung	für	Neuropädiatrie,	
Universitätsklinik	für	Kinderheilkunde	Inselspital
031	632	31	10
Biel/Bienne Zentrum	für	Entwicklungsförderung	(Z.E.N),	
Kloosweg	22,	Biel
032	321	42	00
Chur Neuropädiatrie,	Kantonsspital	Graubünden	(KSGR) 081	256	64	06
Fribourg Neuropédiatrie,	Clinique	de	pédiatrie	Fribourg	(HFR) 026	426	74	17
Genève Service	du	Développement	et	Croissance,	Département	
de	l'Enfant	et	de	L'Adolescent,	Hôpitaux	Universitaires	
de	Genève
022	372	54	91
Lausanne Unité de Développement, 
Centre hospitalier Universitaire Vaudois (CHUV)
021 314 34 69
Luzern Abteilung für Neuropädiatrie, Kinderspital Luzern 041 205 31 70
Neuchâtel Département de Pédiatrie, Hôpital Neuchâtelois 032 713 34 64
St. Gallen KER-Zentrum, Zentrum für Kinderneurologie, 
Entwicklung und Rehabilitation, St. Gallen
071 243 73 32
Thurgau Entwicklungspädiatrisches Zentrum, 
Kantonsspital Münsterlingen (KSM)
071 686 21 65
Ticino Servizio di Neuropediatria, 
Ospedale Regionale di Bellinzona
091 811 91 95
Valais Service de Pédiatrie, Hôpital de Sion 027 603 42 37
Winterthur Sozialpädiatrisches Zentrum, Kantonsspital Winterthur 052 266 29 17
Zürich Abteilung Entwicklungspädiatrie, Kinderspital Zürich 044 266 82 47
Table 1: Developmental	pediatric	and	neuropediatric	units	in	Switzerland	performing	
neurodevelopmental	follow-up	of	high-risk	newborns.
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mental	 outcome	of	 extremely	preterm	born	
children	 is	 determined	 by	 major	 neonatal	
morbidities	 rather	 than	 gestational	 age	 or	
birth	 weight9).	 These	 findings	 have	 a	 direct	
impact	on	parental	counseling	and	the	medi-
cal	decision-making	processes.
Several	obstacles	may	impair	communication	
between	the	neonatal	units	and	the	follow-up	
centers.	 Each	 high-risk	 newborn	 needs	 an	
individual	 invitation	 to	 a	 follow-up	 center.	
However,	 follow-up	 centers	 are	 not	 always	
made	aware	of	the	existence	of	a	patient,	or	
the	patient	 is	not	transferred	to	the	correct	
center.	This	often	happens	when	young	fami-
lies	move	to	settle	at	a	more	permanent	loca-
tion	before	or	at	the	time	when	their	children	
start	school.	To	avoid	the	subsequent	loss	to	
follow-up,	 the	 registry’s	 infrastructure	 pro-
vides	follow-up	units	with	a	constantly	upda-
ted	 list	 from	 which	 the	 units	 can	 see	 who	
needs	follow-up.	If	a	patient	has	moved	to	the	
catchment	area	of	another	unit,	the	registry	
acts	as	a	broker	between	the	old	and	the	new	
unit	so	that	the	new	unit	has	the	information	
it	requires	to	invite	the	patient.	Should	a	pa-
tient	be	unknown	to	a	follow-up	unit	because	
the	unit	has	never	received	a	referral,	the	re-
gistry	provides	the	details	of	the	neonatal	unit	
that	 formerly	 treated	 the	 patient	 and	 can	
perform	the	formal	transfer.	In	each	case,	the	
registry	 itself	 does	 not	 obtain	 any	 personal	
information	other	than	the	birth	date	and	the	
birth	location,	from	which	it	cannot	derive	any	
identification.	 These	 actions	 greatly	 reduce	
loss	of	follow-up.	
One	could	argue	that	better	discipline	in	com-
municating	among	participating	units	would	
be	sufficient	and	would	render	organizational	
assistance	unnecessary.	However,	as	person-
nel	such	as	residents	or	part-time	administra-
tive	assistants	in	participating	units	frequent-
ly	change,	even	the	best	efforts	at	improving	
discipline	 are	 likely	 to	 fail.	 This	 is	 why	 we	
chose	to	follow	the	recommendation	of	qua-
lity	improvement	experts	such	as	Ellsbury	et	
al.	and	invested	in	a	functioning	system	rather	
than	tinkering	with	best	efforts28).	
One	consequence,	however,	is	that	these	re-
cruiting	lists	sometimes	lead	to	the	miscon-
ception	that	follow-up	assessments	are	per-
formed	«because	of	the	registry»	or	even	«for	
the	registry».	This	is	not	the	case,	so	it	is	im-
portant	 to	state	 that	 the	 registry’s	first	and	
foremost	goal	is	to	facilitate	follow-up	assess-
ments	 for	 the	benefit of the child and its 
parents.	The	data	collection	to	 the	registry	
itself	 is	of	secondary	 importance	and	is	de-
pendent	upon	parental	consent,	even	if	it	will	
additionally	benefit	the	population	of	high-risk	
newborns	 as	 discussed	 above.	None	of	 the	
children	are	recruited	simply	or	primarily	for	
the	purpose	of	delivering	data	to	the	registry.
Location of follow-up examinations
Children	born	at	high	risk	for	developmental	
impairment	are	examined	in	a	limited	number	
of	centers	(Table 1).	These	centers	are	specia-
lized	 and	 experienced	 in	 developmental	 as-
sessments	 and	 use	 validated	 and	 standar-
dized	tests	and	questionnaires.	The	centers	
are	 either	 child	 development	 or	 pediatric	
neurology	 centers.	 Pediatricians	 in	 private	
practice	 can	 examine	 high-risk	 children	 for	
the	 registry	 instead	 of	 a	 center	 if	 they	 can	
demonstrate	 comparable	 experience	 and	
training	specific	to	high-risk	newborn	infants	
and	if	they	frequently	use	the	test	batteries	
agreed	upon	by	the	network.	All	participating	
centers	and	pediatricians	need	 to	be	mem-
bers	of	the	Swiss	Neonatal	Network	&	Follow-
up	 Group	 and	 participate	 at	 the	 regular,	
biannual	conferences.	They	enter	the	standar-
dized	data	they	have	acquired	into	the	registry	
as	specified	below.
Contents and milestone ages of 
follow-up examinations
The	 individual	 follow-up	 examinations	 are	
performed	at	intervals	defined	by	each	center	
but	 covering	 the	 jointly	 agreed	cornerstone	
ages.	Correction	for	prematurity	is	made	until	
the	completion	of	the	two-year	examination.
Up	to	two	years,	the	age	at	which	follow-up	
examinations	are	performed	depend	on	 the	
local	tradition	of	follow-up	intervals,	available	
personnel	 and	 the	 regional	 reimbursement	
practices	of	the	disability	insurance	company	
(IV).	At	2 and 5–6 years,	follow-up	examina-
tions	using	the	jointly	agreed	identical	assess-
ment	 batteries	 are	 uniformly	 performed	
throughout	Switzerland	to	ensure	comparabi-
lity	(Fig. 1).	According	to	Vohr	et	al.	(2003),	a	
Neonatal Data is sent to SwissNeoNet:  
SwissNeoNet provides follow-up lists and tables 
for recruitment and/or transfer to other center
3 months – 15 months
individual assessment intervals 
According to center strategy
3–4 Years
Individual assessment intervals 
According to center strategy
Bayley III 
neurological, visual and 
hearing examination
K-ABC II 
neurological, motor, 
visual and hearing examination, 
assessment of behavior
Corr. 18–24 Months
5.5–6 Years
High-risk newborn child
Data is sent to SwissNeoNet: 
all years: bom < 28w GA, ASP with Samat II/III 
2000, 2006, 2013: bom < 32w GA
Data is sent to SwissNeoNet: 
all years: bom < 28w GA, ASP with Samat II/III 
2000, 2006, 2013: bom < 30w GA
NICU organizes follow-up transfer
FU2
FU5
Fig. 1: The	ages	at	which	information	on	outcome	is	collected	for	the	SwissNeoNet.
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valid	 developmental	 examination	 combined	
with	a	neurological	examination	conducted	at	
18–22	months	corrected	age	will	identify	the	
vast	majority	of	children	with	cerebral	palsy	
(CP),	 certainly	 all	 those	 with	 moderate	 or	
severe	 CP.24)	 In	 addition,	 cognitive	 and	 lan-
guage	delay	should	be	assessed	at	that	age,	
if	not	already	diagnosed	by	the	primary	care	
provider,	and	a	special	evaluation	by	a	speech	
and	language	therapist	can	be	initiated	so	as	
to	 guarantee	 appropriate	 treatment.	 In	 the	
case	of	a	cognitive	delay,	early	 intervention	
therapy	 should	 be	 started.	 If	 behavioral	 or	
social	interaction	problems	are	noted	during	
this	exam,	or	if	it	is	unclear	whether	a	deve-
lopmental	 delay	 is	 present,	 specialists	 will	
re-examine	these	children	for	further	testing	
or	refer	children	to	a	child	psychologist.	
At	5–6	years	of	age,	the	evaluation	provides	
valuable	information	on	a	wide	range	of	deve-
lopmental	domains	that	will	help	to	determine	
the	 issue	of	 school	 readiness,	 among	other	
questions.	 Currently,	 this	 assessment	 mi-
lestone	 suffers	 from	 the	 difficulty	 of	 long-
term	tracking	and	high	loss	to	follow-up	asso-
ciated	 in	 part	 with	 long	 periods	 of	 lack	 of	
contact	with	the	parents.	Some	centers	may	
therefore	 assess	 the	 children	 at	 3–4	 years	
using	their	individual	assessment	protocol.	
The	test	batteries	chosen	by	the	center	repre-
sentatives	 of	 the	 SwissNeoNet	 for	 the	 two	
milestone	ages	of	2	and	5–6	years	are	stan-
dardized,	 internationally	 used	 assessment	
tools	with	normative	values29),	30),	31).	Their	use	
will	allow	us	to	compare	outcome	results	with	
those	of	other	centers.	
At 18-24 months corrected age 
(maximum	age	range	15–29	months)
•	Bayley	 Scales	 of	 Infant	 Development	 III	
(Cognition,	Language,	Motor)32)	for	all	child-
ren	born	with	a	gestational	age	below	28	
weeks	or	for	all	children	that	developed	a	
moderate	to	severe	encephalopathy	due	to	
asphyxia	(Fig. 1).	For	all	other	children,	the	
Griffith’s	Test33)	may	be	administered	if	the	
Bayley	Scales	of	Infant	Development	III	are	
not	available	or	in	case	of	time	constraints.
•	Neurological	examination	including	classi-
fication	 of	 cerebral	 palsy	 according	 to	
Surveillance	 of	 Cerebral	 Palsy	 in	 Europe	
(SCPE)34)	and	Palisano’s	gross	motor	func-
tion	classification35)
•	Visual	examination	
	 (incl.	Lang	test)36):	classification	into
•	normal	development	
	 (no	problems	or	minor	problems	not	
	 interfering	with	function)
•	moderate	problems	
	 (e.g.	corrective	glas	ses,	strabism)
•	severe	problems	
	 (severe	visual	impairment	or	blindness)
•	Hearing	examination	to	allow	classification	
into
•	normal	development	
	 (none	or	minor	problem)
•	moderate	(moderate	hearing	impairment	
not	requiring	hearing	aids)
•	severe	(hearing	aids	or	cochlear	implant)
At 5–6 years uncorrected age 
(maximum	age	range	4.5–6.5	years)
•	Intellectual	examination:	Kaufmann	Assess-
ment	Battery	for	Children	(K-ABC)37)*	
•	Neurological	examination:	this	includes	CP	
classification	 according	 to	 SCPE	 and	 the	
gross	 motor	 function	 classification	 sys-
tem35)	
•	Motor	 examination:	 Zurcher	 Neuromotor	
Assessment38)	
•	Assessment	 of	 behavior:	 Strength	 and	
Difficulties	Questionnaire	(SDQ)39)	
•	Visual	examination:	classification	into
•	normal	development	
	 (no	problems	or	minor	problems	not	in-
terfering	with	function)
•	moderate	problems	
	 (reduced	vision	despite	correction)
•	severe	problems	
	 (severe	visual	impairment	or	blindness)
•	Hearing	examination:	classification	into
•	normal	development	
	 (none	or	minor	problem)
•	moderate	(moderate	hearing	impairment	
requiring	hearing	aids)
•	severe	(hearing	impairment	despite	hea-
ring	aids)
To	obtain	outcome	data	comparable	with	pu-
blished	data,	the	participating	centers	must	
reach	a	follow-up	rate	of	at	least	80	%	both	for	
the	two-year	and	for	the	5–6	year	examination	
according	to	the	Standards	for	Levels	of	Neo-
natal	Care	of	the	Swiss	Society	of	Neonato-
logy40)	 and	 to	 international	 recommenda-
tions24).	
Avoiding loss of follow-up
The	online	registry	of	 the	SwissNeoNet	pro-
vides	lists	and	tables	of	eligible	children	ensu-
ring	that	no	high-risk	child	is	forgotten.	Sup-
port	tools	for	follow-up	include	alerts	to	send	
invitations	to	parents	for	follow-up	consulta-
tions,	administrative	transfer	of	children	from	
one	perinatal	center	to	another,	calculation	of	
corrected	 age	 and	 the	 provision	 of	 contact	
information	on	partnering	institutions.	Access	
to	 the	 registry	 is	 restricted	 to	 the	attending	
physicians	and	therapists	of	the	participating	
centers.	 Children	 can	 be	 identified	 via	 their	
encrypted	personalized	data	only	by	the	atten-
ding	physician	or	therapist.	Parents	of	children	
not	yet	covered	by	the	follow-up	program	are	
invited	to	contact	the	follow-up	center	closest	
to	home	for	enrollment,	as	listed	in	Tab. 1.
In	addition	to	the	data	collection	and	manage-
ment	tools,	the	network	fosters	transparent	
multi-center	 research	 and	 quality	 control	
projects	to	maximize	the	benefit	of	maintai-
ning	an	elaborate	database	by	initiating	stu-
dies,	offering	coordination	and/or	statistical	
support,	fostering	collaboration	between	par-
ticipants,	etc.
To	ensure	the	highest	follow-up	rate,	we	re-
commend	these	steps:
•	Families	must	be	made	aware	of	the	impor-
tance	of	follow-up	examinations	during	the	
first	hospitalization	after	birth,	 i.e.	by	 the	
neonatologists.	Neonatologists	must	either	
arrange	the	first	follow-up	examination	di-
rectly	or	send	a	copy	of	the	discharge	re-
port	to	the	follow-up	center	nearest	to	the	
family’s	home	(Tab. 1).
•	Establishment	of	first	contact	between	the	
follow-up	center	and	the	families	should	be	
via	a	secretary	or	a	physician.
•	This	contact	should	be	complemented	by	a	
written	invitation.
•	Twins/triplets	 should	 be	 invited	 simulta-
neously	if	resources	allow.
•	If	parents	refuse	assessment	or	parents	do	
not	 show	 up,	 then	 the	 pediatrician	 res-
ponsible	should	be	informed	so	that	he	or	
she	 can	 contact	 the	 parents	 directly	 and	
inform	them	of	the	purpose	of	the	examina-
tions.
•	If	parents	continue	to	refuse	to	attend	exa-
minations,	 they	 should	 be	 asked	 if	 they	
would	be	willing	to	fill	 in	a	parental	ques-
tionnaire	 that	would	 benefit	 the	 research	
and	quality	control	but	would	be	of	no	di-
rect	benefit	to	the	child	or	its	family.
* The currently used developmental test at 5–6 years 
of age, i.e. the K-ABC, is outdated. While its revised 
version (K-ABC II) is applied in English- and French-
speaking nations, a German version is not yet 
available. The SwissNeoNet representatives have 
therefore decided to wait until 2015 before selec-
ting a replacement assessment battery for K-ABC, 
which must be available for all three major Swiss 
languages.
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Additional information
Additional	 information	 can	 be	 found	 on	 the	
website	of	the	Swiss	Society	of	Neonatology	
under	«Network»:	www.neonet.ch.
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